Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Kido, Shinsuke ^a   Hasebe, Naoyuki ^a   Ishii, Yoshinao ^b   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b ASAHIKAWA CITY HOSPITAL   (Japan)

Author keywords

Atrial and brain natriuretic peptides; Cardiac event; Lactate extraction ratio; Left ventricular diastolic function; Left ventricular outflow tract obstruction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; LACTIC ACID;

ADULT; AORTA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY SINUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM PACING; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRESSURE TRANSDUCER; PRIORITY JOURNAL; PROTEIN SECRETION; TACHYCARDIA; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART LEFT VENTRICLE FUNCTION; HEART PACING; MIDDLE AGED;

ATRIAL NATRIURETIC FACTOR; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; TACHYCARDIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645737467     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00110.2005     Document Type: Article

References (36)

1. Bonow RO and Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med 117: 502-510, 1992.
2. Briguori C, Betocchi S, Manganelli F, Gigante B, Losi MA, Ciampi Q, Gottilla R, Violante A, Tocchetti CG, Volpe M, and Chiariello M. Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy. Eur Heart J 22: 1328-1336, 2001.
3. Cannon III RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watoson RM, and Epstein SE. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 71: 234-243, 1985.
4. Derchi G, Bellone P, Chiarella F, Randazzo M, Zino V, and Vecchio C. Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy. Am J Cardiol 70: 1502-1504, 1992.
5. Devereux RB and Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55: 613-618, 1977.
6. Dilsizian V, Bonow RO, Epstein SE, and Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22: 796-804, 1993.
7. Dupouy P, Geschwind H, Pelle G, Aptecar E, Hittinger L, Ghalid AE, and Dubois-Rande JL. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol 27: 1374-1380, 1996.
8. Friedl W, Mair J, Thomas S, Pichler M, and Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 76: 129-136, 1996.
9. Hasebe N, Shen YT, Kiuchi K, Hittinger L, Bishop SP, and Vatner SF. Enhanced postischemic dysfunction selective to subendocardium in conscious dogs with LV hypertrophy. Am J Physiol Heart Circ Physiol 266: H702-H713, 1994.
10. Hasebe N, Hittinger L, Kohin S, Shen YT, Graham RM, and Vatner SF. Effects of hypertrophy on left atrial and ventricular compliance and plasma ANF levels in conscious dogs. Am J Physiol Heart Circ Physiol 268: H781-H787, 1995.
11. Ikäheimo MJ, Ruskoaho HJ, Airaksinen KEJ, Huikuri HV, Korhonen UR, Leppäluoto PJ, Tuominen MO, and Takkunen JT. Plasma level of atrial natriuretic peptide during myocardial ischemia induced by percutaneous transluminal coronary angioplasty or dynamic exercise. Am Heart J 117: 837-841, 1989.
12. Izawa H, Yokota M, Nagata K, Iwase M, and Sobue T. Impaired response of left ventricular relaxation to exercise-induced adrenergic stimulation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 28: 1738-1745, 1996.
13. Lucarini AR, Marini C, Favilla S, Lattanzi F, Picano E, and Salvetti A. Dipyridamole-induced myocardial ischemia increases ANF release in man. Eur Heart J 12: 732-735, 1991.
14. Mair J, Hammerer-Lercher A, and Puschendorf B. The impact of cardiac natriuretic peptide determination on diagnosis and management of heart failure. Clin Chem Lab Med 39: 571-588, 2001.
15. Maki S, Ikeda H, Muro A, Yoshida N, Shibata A, Koga Y, and Imaizumi T. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 82:774-778, 1998.
16. Maron BJ. Hypertrophic cardiomyopathy. In: Hurst's The Heart (9th ed.). Alexander RW, Schlant RC, and Fuster V, New York: McGraw-Hill, 1998, p. 2057-2074.
17. Maron BJ, Isner JM, and McKenna WJ. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial disease, and mitral valve prolapse. J Am Coll Cardiol 24: 880-885, 1994.
18. Maron MS, Olivotto L, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, and Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348: 295-303, 2003.
19. Masuyama T, Uematsu M, Doi Y, Yamamoto K, Mano T, Naito J, Kondo H, Ngano R, Hori M, and Kamada T. Abnormal coronary flow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: implication for tachycardia-induced myocardial ischemia. J Am Coll Cardiol 24: 1625-1632, 1994.
20. Matsunami T, Yokota M, Iwase M, Watanabe M, Miyahara T, Koide M, Saito H, and Takeuchi J. Dynamic exercise-induced elevation in plasma levels of atrial natriuretic peptide in patients with effort angina pectoris. Am Heart J 120: 1298-1305, 1990.
21. Mukoyama M, Nakao K, Saito Y, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, and Imura H. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, ANP and BNP. J Clin Invest 87: 1402-1412, 1991.
22. Natori S, Hasebe N, Jin YT, Matsusaka T, Ido A, Matsuhashi H, Ihara T, and Kikuchi K. Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure. Am J Respir Crit Care Med 167: 895-901, 2003.
23. Nishigaki K, Tomita M, Kagawa K, Noda T, Minatoguchi S, Oda H, Watanabe S, Morita N, Nakao K, and Fujiwara H. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 28: 1234-1242, 1996.
24. Obata K, Yasue H, Horio Y, Naomi S, Umeda T, Sato T, Miyata A, Kangawa K, and Matsuo H. Increase of human natriuretic peptide in response of cardiac pacing. Am Heart J 113: 845-847, 1987.
25. Ogata Y, Hiyamuta K, Terasawa M, Ohkita Y, Bekki H, Koga Y, and Toshima H. Relationship of exercise or pacing induced ST segment depression and myocardial lactate metabolism in patients with hypertrophic cardiomyopathy. Jpn Heart J 27: 145-158, 1986.
26. Ohta T, Hasebe N, Tsuji S, Izawa K, Jin YT, Kido S, Natori S, Sato M, and Kikuchi K. Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol. Am J Physiol Heart Circ Physiol 287: H2914-H2921, 2004.
27. Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, and Bourassa MG. Pathophysiology of chest pain in patients with cardiomyopathy and normal coronary arteries. Circulation 65: 778-789, 1982.
28. Raff GL and Glantz SA. Volume loading slows left ventricular isovolemic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res 48: 813-824, 1981.
29. Schifrin EL, Gutkowska J, Kuchel O, Cantin M, and Genest J. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med 312: 1196-1197, 1985.
30. Schwartzkopff B, Mundhenke M, and Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol 31: 1089-1096, 1998.
31. Stauffer JC and Gaasch WH. Recognition and treatment of left ventricular diastolic dysfunction. Prog Cardiovasc Dis 32: 319-332, 1990.
32. Takemura G, Fujiwara H, Mukoyama M, Saito Y, Nakao K, Kawamura A, Ishida M, Kida M, Uegaito T, Tanaka M, Matsumori A, Fujiwara T, Imura H, and Kawai C. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 83: 181-190, 1991.
33. Uusimaa PA, Peuhkurinen KJ, Hassinen IE, Vuolteenaho O, and Ruskoaho H. Ischemia stimulates the release of atrial natriuretic peptide from rat cardiac ventricular myocardium in vitro. Life Sci 50: 365-373, 1992.
34. Von Dohlen TW, Prisant LM, and Frank MJ. Significance of positive or negative tallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol 64: 498-508, 1989.
35. Wigle ED, Rakowski H, Kimball BP, and Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92: 1680-1692, 1995.
36. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, and Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide compared with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195-203, 1994.